Aquestive Therapeutics Inc (AQST)
Cost of Revenue
$4.02M
Quarterly · Period ending: · USD
AQST Cost of Revenue
Latest reported$4.02Mperiod ending
Latest reported$4.02Mperiod ending
AQST Quarterly Cost of Revenue ($4.18M → $4.02M)
Quarterly cost of revenue
High-resolution chart · PNG
AQST cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 4,017,000 | |
| 3,469,000 | |
| 5,836,000 | |
| 4,506,000 | |
| 4,561,000 | |
| 3,652,000 | |
| 4,520,000 | |
| 4,437,000 | |
| 4,526,000 | |
| 4,389,000 | |
| 4,679,000 | |
| 4,798,000 | |
| 6,617,000 | |
| 4,737,000 | |
| 5,305,000 | |
| 4,625,000 | |
| 5,242,000 | |
| 4,214,000 | |
| 3,366,000 | |
| 4,400,000 | |
| 4,466,000 | |
| 2,757,000 | |
| 2,788,000 | |
| 2,978,000 | |
| 3,539,000 | |
| 3,659,000 | |
| 6,792,000 | |
| 4,643,000 | |
| 5,420,000 | |
| 3,506,000 | |
| 4,787,000 | |
| 5,592,000 | |
| 4,973,000 | |
| 5,636,000 | |
| 5,615,000 | |
| 4,880,000 | |
| 5,141,000 | |
| 4,184,000 |